p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer (Q48070863)
scientific article
Language:
Current Data About p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
(P31) (Q13442814)
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P304) 1569-1577
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P433) 9
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P478) 4
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P577) Friday, September 1, 1995
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P1433) (Q2720965)
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P1476) "p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer" (language: en)
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

(P2093) Williamson MP
(P1545) 1
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

Elder PA
(P1545) 2
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

Shaw ME
(P1545) 3
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

Devlin J
(P1545) 4
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

Knowles MA
(P1545) 5
(P248)
(P698) 8541841
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8541841

other details
description scientific article

External Links
(P356) 10.1093/HMG/4.9.1569
(P698) 8541841